Dr Reddy’s gets 2 observations from USFDA for Telangana API plant
[ad_1] USFDA inspects Dr. Reddy’s Laboratories API manufacturing plant in Telangana, issues Form 483 with 2 observations. | Photo Credit: SIVAKUMAR PV Dr Reddy’s Laboratories
Dr Reddy’s receives two USFDA observations for API facility in New York
[ad_1] Dr Reddy’s Laboratories has disclosed that the US Food and Drug Administration has issued a Form 483 with two observations following a recent inspection
Cipla gets USFDA nod for generic cancer drug
[ad_1] Cipla’s protein-bound paclitaxel is a generic therapeutic equivalent version of Bristol Myers Squibb’s Abraxane for injectable suspension 100 mg/vial | Photo Credit: DANISH SIDDIQUI
Biocon Biologics gets USFDA approval for Jobevne cancer drug
[ad_1] research chemistry medicine product at science lab | Photo Credit: Artsanova Biocon Biologics, the biosimilar arm of Biocon has expanded its oncology portfolio with
